Results of the primary outcome of the trial—all-cause mortality—are shown according to subgroups that were prespecified in the protocol.
eGFR indicates estimated glomerular filtration rate and NYHA class, New York Heart Association symptom class at time of randomization.
aAmerican Indian, Native Hawaiian, and “multiple” categories were not included due to very small sample sizes.